NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
Clinical trials for NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for older AML patients: drug combo aims to improve outcomes
Disease control Recruiting nowThis study tests a new treatment plan for people aged 60 and older who have been newly diagnosed with acute myeloid leukemia (AML) and cannot have strong chemotherapy. The treatment uses two different drug combinations given one after the other. The goal is to see if this approac…
Matched conditions: NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New hope for older leukemia patients: drug combo aims for better remission
Disease control Recruiting nowThis study tests a new combination of drugs (venetoclax, azacitidine, chidamide, and others) against the standard chemotherapy for adults aged 60-75 with newly diagnosed acute myeloid leukemia (AML). The goal is to see if the new combo leads to more complete remissions and fewer …
Matched conditions: NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated May 12, 2026 13:40 UTC